Cite
Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants.
MLA
Fang, Qizhi, et al. “Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants.” PLoS ONE, vol. 8, no. 4, Apr. 2013, pp. 1–10. EBSCOhost, https://doi.org/10.1371/journal.pone.0061413.
APA
Fang, Q., Mok, P. Y., Thomas, A. E., Haddad, D. J., Saini, S. A., Clifford, B. T., Kapasi, N. K., Danforth, O. M., Usui, M., Ye, W., Luu, E., Sharma, R., Bartel, M. J., Pathmanabhan, J. A., Ang, A. A. S., Sievers, R. E., Lee, R. J., & Springer, M. L. (2013). Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants. PLoS ONE, 8(4), 1–10. https://doi.org/10.1371/journal.pone.0061413
Chicago
Fang, Qizhi, Pamela Y. Mok, Anila E. Thomas, Daniel J. Haddad, Shereen A. Saini, Brian T. Clifford, Neel K. Kapasi, et al. 2013. “Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants.” PLoS ONE 8 (4): 1–10. doi:10.1371/journal.pone.0061413.